4

$PFE · Pfizer Inc.

October 16, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Pfizer filed a Form 4 reporting a transaction by Albert Bourla, the company’s Chairman and CEO. On October 15, 2026, Bourla acquired 20 phantom stock units under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan. Each unit represents one phantom share of Pfizer common stock. These units are settled in cash following his separation from service, and he may transfer them into an alternative investment account at any time.

The reported price for the phantom stock units was $29.44 per unit. After the transaction, Bourla beneficially owned 783,997 phantom stock units directly. The filing does not indicate that the transaction was made under a Rule 10b5-1 trading plan. This is a routine Section 16 beneficial ownership report and does not describe an open-market purchase or sale of actual Pfizer common stock.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →